You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 61 Next »

The purpose of the SDTM Trial Design Model is to represent a brief, clear description of the overall plan and design of a nonclinical study or clinical trial. Trial Design datasets contain study-level, rather than subject-level, information. Guidance in this section is applicable to TIG Nonclinical and Product Impact on Individual Health use cases only. In this section, the term "trial" is equivalent to "study" in the nonclinical context. The TIG guides implementation of the Trial Design datasets described in the table below for use cases as indicated. 


NumDatasetPurposeUse Case(s)
1Trial Arms (TA)

Represents each planned arm in the trial including the sequences of elements in each epoch for each arm.

  • Nonclinical
  • Product Impact on Individual Health
2

Trial Elements (TE) 

Represents the elements used in the trial including unique codes for each element, element descriptions, and the rules for starting and ending an element.

  • Nonclinical
  • Product Impact on Individual Health
3Trial Visits (TV)Represents the planned order and number of visits in the trial within each arm.
  • Product Impact on Individual Health
4Trial Inclusion/Exclusion (TI)

Represents the inclusion and exclusion criteria for the trial.


  • Product Impact on Individual Health
5Trial Summary (TS)

Represents key summary characteristics for the trial.

  • Nonclinical
  • Product Impact on Individual Health
6Trial Sets (TX)

Represents planned sets of subjects that result from combinations of experimental factors defined for the trial.

  • Nonclinical

  • No labels